Citius Pharmaceuticals, Inc. — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
Citius Pharmaceuticals (market cap ~$11.4M) received notice on August 17, 2026, from its listing exchange regarding failure to satisfy continued listing rules or standards, triggering potential transfer of listing or delisting proceedings. No specific remediation timeline, financial threshold details, or counterparty terms are disclosed in the filing document provided.
Why this rating
Delisting notice is existential threat to micro-cap company; represents potential loss of public market access and shareholder value destruction regardless of underlying operational merit.
Extracted items
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.